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Abstract Oscillations of free intracellular calcium 1Ca2÷]i were 
seen in individual Jurkat cells as response to a 50 Hz, 0.15 mT 
magnetic field (MF). In contrast, a CD45-deficient Jurkat cell 
line was unable to respond to MF stimulation. The phosphatase 
activity of CD45 has been implicated to regulate p56 tck tyrosine 
kinase activity by removing an inhibitory phosphate. By using 
Jurkat cells that expressed a chimeric molecule, comprising the 
cytoplasmic phosphatase domain of CD45, the MF induced cal- 
cium response was restored. This showed the necessity for an 
intact signal transduction pathway leading to a calcium increase 
as a result of stimulation of cells by ME Thus, our data suggest 
that the target for the applied MF are molecules involved in early 
events in the signalling pathway from the T cell antigen receptor. 
Key words: Signal transduction; Jurkat T-cell line; CD45 
phosphatase; Intracellular calcium; Low frequency magnetic 
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I. Introduction 
A diversity of biological effects has been attributed to expo- 
sure of low frequency magnetic fields to cells of the immune 
system (reviewed in [1]), and epidemiological studies have at- 
tracted public concern, as they suggest a relationship between 
residential MF exposure from high-voltage transmission lines 
and childhood cancers [2]. In vitro studies on molecular and cell 
biological parameters such as increased calcium influx and in- 
duction of c-myc transcripts upon MF exposure has been re- 
ported [3]. Analysis of transcript levels for c-fos and c-myc 
suggests an incrase due to MF exposure [4,5]. However, yet so 
far no molecular targets have been identified through which 
MF exert these effects and the biophysical mechanism of inter- 
action remains imilarly obscure. The main problem is the lack 
of understanding which parameters of the field and of the 
biological system that are critical and responsible for the inter- 
actions. 
To identify candidate molecular targets, we have set up an 
experimental system with the human T cell leukemic line Jur- 
kat, in which the signal transduction pathway - -  from the T cell 
*Corresponding author. Fax: (46) (90) 77-1420. 
Abbreviations: ELF, extremely ow frequency; [CaZ+]~, cytoplasmic free 
calcium concentration; Kd, dissociation constant; Mab, monoclonal 
antibody; MF, magnetic field; protein tyrosine kinase; PTK; protein 
tyrosine phoshpatase, PTPase; T, Tesla; TCR, T cell receptor complex; 
Ti, T cell receptor c~ and ,8 chains. 
receptor to activation of transcription of several genes - -  is 
known in considerable detail. The molecules of the T cell anti- 
gen receptor (TCR) complex have no intrinsic tyrosine kinase 
or phosphatase activities, but phosphorylation and de-phos- 
phorylation are important immediate/early events in T cell acti- 
vation. The antigen-binding subunits form a complex with the 
invariant chains of CD3: the e, y and ~ chains and the ( dimers. 
The cytoplasmic domains of those are responsible for coupling 
the Ti subunit to the intracellular signalling machinery. Gene 
products involved in these signalling pathways include the tyro- 
sine kinases ZAP-70 and Syk and members of the src family of 
protein tyrosine kinases (PTKs), p56/'k and p59/y', as well as the 
protein tyrosine phosphatase (PTPase) CD45. Lck interacts in 
Jurkat cells with the cytoplasmic domain of the co-receptor 
CD4 which upon interaction with the MHC complex are 
brought in close contact with the CD3 complex, resulting in 
phosphorylation of the antigen recognition activation motif 
(ARAM) amino acid sequences at the CD3 cytoplasmic chains 
[6,7,8]. ZAP-70 is associated with the phosphorylated (-chains 
through SH2-phosphotyrosine teractions [9]. The protein-ty- 
rosine phosphorylation can be induced by stimulating the func- 
tion of PTKs, or by inhibiting the PTPases. The tyrosine phos- 
phorylation of phospholipase-C),l (PLCy0 is evident upon 
TCR stimulation and requires an intact CD45 PTPase activity 
[10]. PLCg I is an enzyme that hydrolyses phospahtidyl-inositol 
bisphosphate (PIP2) to diacylglycerol (DAG) and inositol 1,4,5- 
trisphosphate (IP3). When IP3 binds to the specific receptor 
(IP3R) it causes a rise in [Ca2+]i in Jurkat cells [11]. 
In a previous tudy we have registered an oscillatory [Ca2+]~ 
increase (up to ten times the basal evels) in single Jurkat cells. 
By using EGTA in the perfusion buffer, influx of extracellular 
calcium was found to be the predominant reason for the ele- 
vated levels of calcium within the cell [12]. The [Ca2+]~ oscilla- 
tions have further been characterised with respect o frequen- 
cies between 5 and 100 Hz and flux densities up to 0.3 mT and 
found to be maximal for 50 Hz, 0.15 mT [13]. The observed 
calcium response pattern was similar to that measured for an 
anti-CD3 monoclonal antibody, both in amplitude and the lag 
time before the Ca-oscillations started. We have also measured 
the generation of the phosphatidylinositol second messenger 
1P3 in Jurkat cells and found the maximal concentration ap- 
peared 2 rain after the start of the MF exposure [14]. These 
findings exclude that depolarisation of the plasma-membrane, 
or direct interaction with calcium ions are the primary targets 
for the MF. 
To elucidate if MF has targets along a pathway upstream of 
PLCyl we have used the mutant Jurkat cell line with diminished 
CD45 activity, J45.01, to examine the requirement for the 
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CD45 phosphatase activity for MF induced increase in [Ca2+]i . 
CD45 is a family of glycoproteins ranging from 180 to 220 kDa, 
present on all nucleated hematopoietic cells and is the major 
PTPase in T cells. Loss of CD45 expression in cells results in 
spontaneous tyrosine hyper-phosphorylation f a number of 
proteins, such as the TCR ~" subunit and the Src family PTK 
p56 ~'* [7,15]. It has previously been shown that expression of 
the extracellular domain of CD45 is not required for coupling 
of the TCR to its signalling machinery [16,17]. On the other 
hand, expression of the cytoplasmatic phosphatase domain of 
CD45 was shown to restore TCR signalling in a CD45- cell line 
[18]. The suggested role of CD45 in regulating TCR signalling 
includes dephosphorylation f the regulatory C-terminal tyro- 
sine (505) of Lck, allowing an open active conformation of Lck 
which enables it to phosphorylate protein tyrosine kinase sub- 
strates and to keep the kinase active for participation in the 
signal transmission [19,20,21]. CD45 PTPase has been shown 
to affect early events in TCR-mediated signalling, and CD45 
negative cells fails to couple to the phosphatidylinositol second 
messenger pathway [10]. 
In this study we show that Jurkat cells only responds to the 
MF  if the cells have intact expressed the intracellular domain 
of CD45. 
2. Materials and methods 
2.1. Measurements of intracellular calcium 
Measurements of [Ca2+]~ after pre-incubation with the calcium bind- 
ing probe fura-2/AM, 2 ¢tM, on poly-L-lysine coated glass (0.01%) has 
been described previously [13]. Briefly, attached cells were placed in a 
perfusion chamber and real-time fluorescence was measured at 37°C. 
The [Ca2+]i in single cells was calculated from the ratio of emitted light 
at 510 nm, measured with a photomultiplier when the cells were illumi- 
nated with 340 nm or 380 nm excitation light, respectively. The calibra- 
tion of the fura-2 signal has been described [13], using a Kd of 231 riM. 
We had one criterion for selection of individual cells to test of the effect 
of MF: the cell should not show fura-2 fluctuations 4 rain before start 
of MF exposure. Cells that fluctuated more than 20% in their basal 
values were sorted out and from previous experience we know that such 
cells only rarely respond to antibodies or other stimuli. Only one exper- 
iment per cover glass was done and the recording time was less than 
15 rain. The figures shown are representative forat least seven individ- 
ual experiments. A positive response to MF is defined as at least a 
threefold increase of the maximal peak value in [Ca2+]i. 
2.2. Jurkat cell lines 
The human leukemic T cell line Jurkat and derivative clones were 
obtained from Dr. Gary Koretzky, University of Iowa, USA. The 
following clones of Jurkat were used in this study: Jurkat (clone E6-1); 
wildtype, J45.01; Jurkat clone with diminished phosphatase activity 
[10], J451CH11 chimera; Jurkat clone with reconstituted phosphatase 
activity (transfected with cytooplasmic part of CD45 and fused with the 
extra cellular and the transmembrane s quences from plasmid A2, 
encoding the MHC class I [18]), J451A2; Jurkat CD45- MHC I ÷ control 
clone (J45.01 transfected with the A2 plasmid). Cells used for experi- 
ments were in logarithmic phase in RPMI 1640 medium supplemented 
with 10% FCS, 2 mM L-glutamine and cultured in a Forma-incubator, 
5% CO2 in air, rebuilt to keep the internal ELF stray fields less than 
0.2/zT. 
2.3. MF exposure system 
A homogenous vertical magnetic field was generated by a pair of 
Helmholtz' coils mounted on the objective stage. The coils had a diam- 
eter of 10 cm and were made of 20 turns of 0.6 mm diameter enamelled 
copper wire. The distance between the coils was 5 cm. The coils were 
fed from a signal generator and an amplifier and the current was 
switched on by closing the circuit [13]. The magnetic field at the centre 
between the coils (i.e. at the place where the cells were located) were 
both calculated from the current in the coils, as well as measured with 
a Bell 640 Gauss meter equipped with a 3-axis probe and a small pickup 
coil (200 turns, 3.5 cm diameter) connected to a voltmeter. The current 
in the coils was adjusted to give a flux density of 0.15 mT. When the 
same current was applied to the coils in a test set outside the microscope 
a slightly higher eading was obtained, thus indicating a small distortion 
due to the metallic structure of the objective stage of the microscopes. 
Measurements at the place of the cells gave a total flux density 64/tT 
and the vertical components of the geomagnetic f eld at the site of the 
cells was 48 ¢tT. The environmental stray ELF fields in the room was 
below 0.2/IT. 
2.4. Fluorometric analysis 
Flow cytometry was performed with a FACScan fluorcytometer 
(Becton Dickinson, Mountain View, CA, USA). Analysis of 106 cells 
stained on ice for 35 rain was done with the following monoclonal 
antibodies (Mabs): goat anti-mouse-FITC, anti-CD19, -CD2, -CD4, 
-CD45 and anti-TCR, all from Becton Dickinson. Anti-CD3 Mab 
UCHT-1 from Dako A/S (Copenhagen, Denmark). Cells were washed 
and then stained 35 min on ice with secondary Mab-FITC. Fluores- 
cence data of 10,000 cells was collected, using logarithmic amplification 
and the fluorescence for each antibody was quantified using the single 
histogram statistics program setting the marker at fixed position. 
3. Results 
Jurkat cells exposed to 50 Hz, 0.15 roT, responded with an 
increase in [Ca2+]i that started within 120 s after the onset of the 
MF and lasted during the exposure time. The oscillating Ca 2+ 
spikes in the different single cells examined reached amaximum 
of 500-900 nM (Fig. 1A). In contrast, testing J45.01 cells, a 
mutant Jurkat clone with markedly reduced surface expression 
of CD45 (Fig. 2), we found no increase in [Ca2+]i when these 
cells were exposed to 50 Hz, 0.15 mT, sinusoidal MF  (Fig. 113). 
These ceils were unresponsive also upon stimulation with an 
anti-CD3-e Mab (data not shown), confirming what others 
earlier have demonstrated using an anti-TCR-fl Mab as stimu- 
lus [10]. These data suggest hat CD45 is required for coupling 
to the inositol signalling pathway resulting in [Ca2+]i ncrease 
upon stimulating cells with MF, in analogy with the need for 
CD45 to transduce the signal upon stimulation by anti-CD3 
antibodies. 
To decide if the response to MF  was determined by the 
phosphatase activity and/or if also the extracellular part of 
CD45 was necessary, we tested the Jurkat clone J45/CH 11. This 
clone expresses only the cytoplasmic domain of CD45 including 
Table 1 
Staining characteristics of the Jurkat clones used for exposure to MF, expressed as percentage positively stained cells of the total number of cells 
analysed. 
Jurkat clone Second Irrel. a-CD2 A-CD3 a-CD4 a-CD45 a-TCR 
antibody antibody 
Jurkat 5 4 70 86 30 99 91 
J45.01 3 4 94 86 15 21 96 
J451A2 2 2 26 10 3 21 40 
J451CHll 2 4 98 80 60 21 73 
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Fig. 1. [Ca2÷]~ measurements in Jurkat cell clones. 50 Hz, 0.15 mT MF was applied at time indicated and at the end of the experiment ionomycin 
(1Bg/ml) was added, as a positive control. (A) Jurkat (clone E6-1) (B) J45.01, Jurkat clone with diminished phosphatase activity [10] (C) J45/CH11 
chimera, Jurkat clone with reconstituted phosphatase activity [18]. (D) J45/A2 without phosphatase activity, control to J45/CH11 (see section 2 for 
details). 
the two subdomains of the PTPase and the extracellular part 
HLA-A2 has no similarity to CD45. Fig. IC shows that this 
Jurkat clone responded in the same way as the wild type Jurkat, 
which indicates that the cytoplasmic part of CD45 containing 
the phosphatase domain was necessary for coupling to PLCyj 
and the ensuing increase in [Ca2÷]~ as a response to MF stimu- 
lation. As a negative control we used the Jurkat clone J45/A2, 
which has the same construct as the chimera but lacks the 
cytoplasmic part of CD45. No response, to either MF or anti- 
CD3, was observed in this clone (Fig. 1D). 
Flow cytometry was performed to analyse the expression of 
TCR accessory molecules. The different clones of Jurkat 
stained equally well for control secondary Mab and for the 
irrelevant anti-B cell marker (Table 1). The two CD45- clones 
J45.01 and J45/A2, stained much less than wild type Jurkat cells 
for CD45. Additionally, J45/A2 stained also less for CD2, CD3, 
CD4 and Ti compared to wild type Jurkat cells (Table 1). 
4. D iscuss ion  
The T cell receptor complex generates signals essential for T 
cell activation upon recognition of antigen. The degree of acti- 
vation by receptor ligation is greatly enhanced when corecep- 
tors are engaged at the same time. This modulation results from 
the interplay between molecules associated with the cytoplas- 
mic tails of the TCR-associated CD3, the ~" proteins and CD4 
[22]. T lymphocytes xpress abundantly a transmembrane tyro- 
sine phosphatase, CD45 that is required for effective signalling. 
It appears that the TCR is a flexible signalling complex of 
proteins that can produce variable ffects depending upon how 
it is ligated (reviewed in [23]). In the intricate molecular balance 
that exists to activate the phosphatidyl-inositol second messen- 
ger pathway, it is difficult to pinpoint the role for individual 
proteins. 
The CD45 extracellular domain is 391-552 amino acids in 
length, depending on the isoforms generated by alternate 
mRNA splicing. One isoform is recognised by the monoclonal 
antibody CD45R0, and is preferentially expressed on memory 
and helper T-cell subsets. One ligand is identified as the B-cell 
specific adhesion molecule CD22 [24]. It has been proposed that 
interaction between extracellular CD45 and accessory mole- 
cules on T cells may participate in modulation of the signalling 
cascade [25,26]. We have found that MF had a stimulatory 
effect of PLCyl activation, measured as increased [Ca2+]i, rre- 
spective of whether the extracellular part of CD45 was ex- 
pressed or not (compare Fig. 1B and C). The requirement for 
CD45 in T cell activation seems to reside at a very early stage 
in the signal transduction cascade, since in the absence of 
CD45, the rapid receptor-triggered tyrosine phosphorylation f 
cellular proteins is severely reduced and results in impaired 
activation of phospholipase C [21]. Although formally not ex- 
cluded, we do not think that CD45 is the prime target for the 
applied MF. However, our experiments shows that MF exerts 
its effects on the signalling cascade from the TcR. The necessity 
of an intact PTPase activity hints to the possibility of interfer- 
ence with phosphorylation events as a possble mechanism. In 
the CD45 deficient cells, also the levels of accessory molecules 
were reduced to different degrees (Table 1). The CD45- clone 
J45.01 was low in CD4 molecule density, an important mole- 
cule in the regulatory network that controls the influx of ex- 
tracellular calcium during T cell activation [27]. We do not 
know whether low CD4 level is related to the reduced CD45 
expression or represent a clonal variation. The association be- 
tween CD45 and Lck has been shown not to require the expres- 
sion of, or activation of the TCR [28], thus making CD4 or Lck 
as possible target candidates for the effect of MF. 
This report demonstrates that the possible targets for the 
effect of weak MF in Jurkat cells are initial molecules along the 
pathway from the TCR complex, with its accessory molecules, 
down to events regulating [Ca2÷]i which was used as a readout 
E. Lindstr6m et al./FEBS Letters 370 (1995) 118 122 121 
~ TcR 
[~  1~i ir~ 113~ I~  4 
Log fluorescence intensity 
1~ 
O 
.~ 
,.,,, 
c~ CD3 
,~': 
- i , '  
, ;~ .,i~. ~ "~ .~.~a 
-7 ~-~-~~,~~,~-~- - r~-~ ..... 
1~ i~ 1~t! 1~2 1~ .~4 
Log fluorescence intensity 
ic~e~ 
o 
o > 
t~ 
i i i 1~9~1,  14P~, ,  1~9, ,  1~9,  ~ I: 
(~ CD4 
- - - - - r - - r - -~r r l - - r - - - r - - t - r~- I  ~,, ', ~ i 'i J irt 
1[~ 1C~1 It~ ~ 1~ ~ 1 
Log fluorescence intensity 
tom 
] 
;f.'. 
~ ~ ' ~ 1 ' "  r"~,~-T-~n~ 
1~ t~ IQ  1 l ib  2 1R  ~ 11;14 
Log fluorescence intensity 
Fig. 2. Immunofluorescence staining of TcR Ti, CD3, CD4 and CD45 surface xpression characteristics ofthe Jurkat clones: E(~I (solid lines), J45.01 
(dotted lines), J45/A2 (shaded lines) and J45/CH11 (dashed lines)• 
in these experiments. As the effect of MF here seen is of the 
same order as that seen upon crosslinking the TCR complex, 
we think it would be possible to analyse changes in phosphoryl- 
ation pattern of molecules involved in the early signal transduc- 
tion events. Thus, the strategy is to identify target molecules for 
later mutational analysis in order to set up a biophysical expla- 
nation of our observation• 
There exists a controversy about the mechanism for the bio- 
logical effects of weak MF. One argument is that the effects of 
weak fields will be masked by thermal noise energies [29]. Oth- 
ers have shown that when the limit between an applied field and 
the thermal noise is small, the weak fields cannot be dismisssed 
[30]. It is premature to speculate how weak MF may act before 
a target molecule or target molecule complexes for MF are 
identified• 
The approach used demonstrates the necessity for expression 
of the cytoplasmic domain of CD45 including its phosphatase 
domain, suggesting that MF uses the same signalling pathway 
to induce [Ca2+]i oscillations as that used during anti-CD3 stim- 
ulation. 
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